ROTHBLATT MARTINE A (Chairperson & CEO) sold 2.8% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $5.32M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+9.50K
Price / share
$117.76
Trade value
$1.12M
% of position
Common Stock
Shares
−46.00
Price / share
$552.52
Trade value
$25.42K
% of position
Common Stock
Shares
−194.00
Price / share
$553.78
Trade value
$107.43K
% of position
Common Stock
Shares
−550.00
Price / share
$555.19
Trade value
$305.36K
% of position
Common Stock
Shares
−567.00
Price / share
$556.41
Trade value
$315.49K
% of position
Common Stock
Shares
−1.70K
Price / share
$557.25
Trade value
$948.43K
% of position
Common Stock
Shares
−1.14K
Price / share
$558.32
Trade value
$634.81K
% of position
Common Stock
Shares
−743.00
Price / share
$559.25
Trade value
$415.52K
% of position
Common Stock
Shares
−820.00
Price / share
$560.50
Trade value
$459.61K
% of position
Common Stock
Shares
−200.00
Price / share
$561.44
Trade value
$112.29K
% of position
Common Stock
Shares
−960.00
Price / share
$562.54
Trade value
$540.04K
% of position
Common Stock
Shares
−1.25K
Price / share
$563.43
Trade value
$705.97K
% of position
Common Stock
Shares
−768.00
Price / share
$564.63
Trade value
$433.64K
% of position
Common Stock
Shares
−480.00
Price / share
$565.36
Trade value
$271.37K
% of position
Common Stock
Shares
−80.00
Price / share
$566.43
Trade value
$45.31K
% of position
Net shares
+0.00
Net value
-$4.20M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/21/2026 | M · Option Exercise | +9.50K | $117.76 | $1.12M | 2.9% | 324.44K | 333.94K |
| Common Stock Indirect | 10/21/2026 | S · Sale | −46.00 | $552.52 | $25.42K | 0.0% | 333.94K | 333.90K |
| Common Stock Indirect | 10/21/2026 | S · Sale | −194.00 | $553.78 | $107.43K | 0.1% | 333.90K | 333.70K |
| Common Stock Indirect | 10/21/2026 | S · Sale | −550.00 | $555.19 | $305.36K | 0.2% | 333.70K | 333.15K |
| Common Stock Indirect | 10/21/2026 | S · Sale | −567.00 | $556.41 | $315.49K | 0.2% | 333.15K | 332.59K |
| Common Stock Indirect | 10/21/2026 | S · Sale | −1.70K | $557.25 | $948.43K | 0.5% | 332.59K | 330.88K |
| Common Stock Indirect | 10/21/2026 | S · Sale | −1.14K | $558.32 | $634.81K | 0.3% | 330.88K | 329.75K |
| Common Stock Indirect | 10/21/2026 | S · Sale | −743.00 | $559.25 | $415.52K | 0.2% | 329.75K | 329K |
| Common Stock Indirect | 10/21/2026 | S · Sale | −820.00 | $560.50 | $459.61K | 0.2% | 329K | 328.18K |
| Common Stock Indirect | 10/21/2026 | S · Sale | −200.00 | $561.44 | $112.29K | 0.1% | 328.18K | 327.98K |
| Common Stock Indirect | 10/21/2026 | S · Sale | −960.00 | $562.54 | $540.04K | 0.3% | 327.98K | 327.02K |
| Common Stock Indirect | 10/21/2026 | S · Sale | −1.25K | $563.43 | $705.97K | 0.4% | 327.02K | 325.77K |
| Common Stock Indirect | 10/21/2026 | S · Sale | −768.00 | $564.63 | $433.64K | 0.2% | 325.77K | 325K |
| Common Stock Indirect | 10/21/2026 | S · Sale | −480.00 | $565.36 | $271.37K | 0.1% | 325K | 324.52K |
| Common Stock Indirect | 10/21/2026 | S · Sale | −80.00 | $566.43 | $45.31K | 0.0% | 324.52K | 324.44K |
| Total | +0.00 | -$4.20M | ||||||
Stock Option
Common Stock
9.50K shares
Shares
−9.50K
Strike price
117.76
Held after
185.91K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Indirect | Common Stock9.50K shares | 10/21/2026 | M · Option Exercise | −9.50K | 117.76 | — | 185.91K |
Common Stock
IndirectCommon Stock
IndirectCommon Stock
DirectCommon Stock
IndirectCommon Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 45.60K | Indirect |
| Common Stock | 249.11K | Indirect |
| Common Stock | 40.51K | Direct |
| Common Stock | 166.00 | Indirect |
| Common Stock | 8.90K | Indirect |
| Total | 344.29K | 40.51K direct·303.77K indirect |